MarketPulse — Real-Time Financial News & Market Analysis

S&P 500 faces bearish technical pressure toward 6400 amid elevated VIX and global bond stress, though Trump's Iran de-escalation comments provide near-term relief.

Ekinops acquires French ZTNA startup Chimere to strengthen its SASE portfolio and claim position as Europe's sole single-vendor SASE provider.

S&P 500 futures reverse after Iran denies deal talks contradicting Trump's Monday announcement. Oil recovers overnight amid diplomatic uncertainty while manufacturing PMI data looms.

Nvidia stock could gain 74% to $300 by 2030 despite current 7% YTD decline, as CEO projects $1 trillion revenue from next-gen chips.

Roche launches cobas eplex RP3, detecting 25 pathogens simultaneously across CE markets, enabling faster clinical decisions and improved patient outcomes.

Pharming secures Japan approval for Joenja, first APDS treatment for children aged 4-11 globally, based on positive Phase III data showing lymphadenopathy reduction and immune function improvement.

DSM-Firmenich initiated €540M share repurchase program on March 12, 2026. By March 20, company bought back 652,398 shares at €58.81 average price.

Dupixent receives Japanese marketing authorization for bullous pemphigoid, becoming the first targeted treatment. Study showed 18% remission rate versus 4% for placebo.

Sanofi and Regeneron's Dupixent secured Japanese regulatory approval for bullous pemphigoid, marking the drug's seventh indication in Japan with superior remission rates versus placebo.

Estée Lauder shares fell 7.72% to $79.29 after announcing preliminary merger discussions with Spanish luxury giant Puig Brands. No final decision made; deal pending regulatory approval.

Hormel and General Mills trade at depressed valuations with 5.2% and 6.5% dividend yields amid consumer spending concerns and GLP-1 drug headwinds.

Phonak's AI hearing aids win 2026 excellence awards, featuring advanced environmental recognition and neural networks for improved speech clarity in noisy settings.

Beyond Meat faces securities class action over alleged asset impairment misstatements; lead plaintiff deadline is March 24, 2026.

Rosen Law Firm notifies Corcept investors about securities lawsuit alleging misrepresentation of relacorilant clinical data and concealment of FDA concerns during October 2024-December 2025.

Rosen Law Firm filed securities class action against Concorde International Group ($CIGL) alleging fraudulent promotion schemes and insider share dumping. Affected investors must act before critical deadlines.

BlackRock TCP Capital faces securities lawsuit alleging NAV overstatement and misvaluation. Investors have until April 6, 2026, to join the class action.

Yimutian Inc. acquires enterprise e-commerce platform Ningbo Xunxi Technology for RMB 50 million, expanding beyond agricultural supply chains into digital procurement.

Yimutian acquires Ningbo Xunxi Technology for RMB 50M to combine agricultural supply platform with enterprise procurement capabilities, targeting China's growing digital commerce sector.

Explosion at Valero's Port Arthur refinery causes minor stock decline; 380,000 bpd capacity facility's production impact remains unclear.

Palantir surged 23% in one month on 70% revenue growth and 137% U.S. commercial expansion, but extreme P/E ratio of 255 raises valuation concerns despite solid fundamentals.